Cargando…

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis

Detalles Bibliográficos
Autores principales: Finetti, M, Insalaco, A, Cantarini, L, D'Alessandro, M, Meini, A, Breda, L, Alessio, M, Picco, P, Martini, A, Gattorno, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044188/
http://dx.doi.org/10.1186/1546-0096-11-S2-P323
_version_ 1782319101338714112
author Finetti, M
Insalaco, A
Cantarini, L
D'Alessandro, M
Meini, A
Breda, L
Alessio, M
Picco, P
Martini, A
Gattorno, M
author_facet Finetti, M
Insalaco, A
Cantarini, L
D'Alessandro, M
Meini, A
Breda, L
Alessio, M
Picco, P
Martini, A
Gattorno, M
author_sort Finetti, M
collection PubMed
description
format Online
Article
Text
id pubmed-4044188
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40441882014-06-17 PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis Finetti, M Insalaco, A Cantarini, L D'Alessandro, M Meini, A Breda, L Alessio, M Picco, P Martini, A Gattorno, M Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044188/ http://dx.doi.org/10.1186/1546-0096-11-S2-P323 Text en Copyright © 2013 Finetti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Finetti, M
Insalaco, A
Cantarini, L
D'Alessandro, M
Meini, A
Breda, L
Alessio, M
Picco, P
Martini, A
Gattorno, M
PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
title PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
title_full PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
title_fullStr PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
title_full_unstemmed PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
title_short PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
title_sort pres-final-2333: long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044188/
http://dx.doi.org/10.1186/1546-0096-11-S2-P323
work_keys_str_mv AT finettim presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT insalacoa presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT cantarinil presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT dalessandrom presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT meinia presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT bredal presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT alessiom presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT piccop presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT martinia presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis
AT gattornom presfinal2333longtermefficacyofinterleukin1receptorantagonistanakinrainamulticentriccohortofpatientsaffectedbyidiopathicrecurrentpericarditis